Loading provider…
Loading provider…
Hematology & Oncology Physician in Cumberland, MD
NPI: 1336137876Primary Practice Location
WESTERN MARYLAND REGIONAL MEDICAL CENTER
12500 Willowbrook Rd, Cumberland, MD
Primary Employer
UPMC Western Maryland Health Services, LLC
upmc.com
HQ Phone
Get MD Blanche's Phone NumberMobile
Get MD Blanche's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardDC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 329 | 811 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 323 | 405 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 84 | 95 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 57 | 57 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 53 | 57 |
Efficacy of solubilized vemurafenib administered via nasogastric tube.
Authors: Farhad Khimani, Christina Hoban, Vicky Williams, Blanche Mavromatis, Miklos Auber, Jame Abraham, Gerald Higa
Publication Date: 2014-02-05
Authors: Samuel Rubinstein, Jeremy Warner, Karen Russell, Monika Joshi, Howard Zaren, Ulysses Wu, Rahul Nanchal, Melissa Accordino, Matthew Puc, Ryann Quinn, Bryan Faller, Lisa Weissmann, Sunny R K Singh, Toni Choueiri, Praveen Vikas
Journal: Lancet Reg Health Am
Publication Date: 2023-02-13
Authors: Hatem Soliman, Rubina Qamar, Ellis Levine, Raye Budway, Michaela Tsai, Shelly Lo, Pat Whitworth
Journal: JAMA Oncol
Publication Date: 2018-01-11
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Computed Tomography
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Fluorouracil, DRUG: Bevacizumab, DRUG: Oxaliplatin, DRUG: Irinotecan, DIETARY_SUPPLEMENT: Cholecalciferol, DRUG: Irinotecan Hydrochloride, DRUG: Leucovorin Calcium
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Rucaparib